CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 33922-34127 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T200","span":{"begin":0,"end":205},"obj":"Sentence"},{"id":"T17193","span":{"begin":0,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Reverse genetics also was used to create RSV subgroup B vaccine candidates by replacing the G and F protective antigen genes of RSV subgroup A vaccine candidates with their subgroup B G and F counterparts."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T200","span":{"begin":0,"end":205},"obj":"Sentence"}],"text":"Reverse genetics also was used to create RSV subgroup B vaccine candidates by replacing the G and F protective antigen genes of RSV subgroup A vaccine candidates with their subgroup B G and F counterparts."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T205","span":{"begin":22,"end":25},"obj":"Disease"}],"attributes":[{"id":"A205","pred":"mondo_id","subj":"T205","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"Reverse genetics also was used to create RSV subgroup B vaccine candidates by replacing the G and F protective antigen genes of RSV subgroup A vaccine candidates with their subgroup B G and F counterparts."}